Plant Manager
Sirtex
Summary
The Wilmington plant is the largest of 3 global Sirtex manufacturing sites and serves as the principal production site of both SIR-Spheres microspheres and Lava product lines. The Plant Manager is responsible for leading the site's manufacturing operations, engineering, warehouse and product distribution.
Job description
Scope
The Wilmington plant is the largest of 3 global Sirtex manufacturing sites and serves as the principal production site of both SIR-Spheres microspheres and Lava product lines. The Plant Manager is responsible for leading the site's manufacturing operations, engineering, warehouse and product distribution.
Primary Responsibilities
- Develop and lead execution of the site manufacturing strategy for both the SIR-Spheres and Lava value streams; align site goals with Senior Leadership and Corporate objectives.
- Team Performance Management: lead, develop and mentor manufacturing team members.
- Manage production schedules, ensuring resource availability and capacity to meet demand, working closely with the Supply Chain team, using optimal schedules to minimize overall costs.
- Lead Continuous Improvement efforts, identifying process, equipment, product, and other opportunities that reduce cost, improve quality and safety at the site.
- Full responsibility for developing and managing to site budget.
- Ensure resource and equipment capacity to ensure efficient and reliable manufacturing.
- Set site target KPIs managing OEE, Labor Efficiency, Scrap, Equipment Utilization, etc.
- Ensure product is built to specification and in compliance with all Quality System requirements.
- Manage the site engineering team to ensure equipment and processes are robust and meet all manufacturing requirements; manage PM strategy and ensure execution is completed on time.
- Support the Quality Department, working with on-site Quality team members to ensure compliance with all areas of the Sirtex QMS; identify opportunities for improvement and implement them directly in the QMS.
- Work in conjunction with HSE/Facilities Department to ensure a safe working environment for all employees and that the facility is maintained and compliant with regulatory requirements for both the handling of radioactive materials and medical device manufacturing.
- Manage all shipping, receiving and warehousing activities; ensure timely material receipt, inventory accuracy is maintained, and products are shipped on time.
Qualifications
- Bachelor's Degree in Engineering or related discipline such as Chemistry or Biomedical field
- 5+ Years experience working in medical device or pharmaceutical industry preferred
- Prior experience working with radioisotopes preferred
- 3+ years of site management experience, with 10+ years of leadership experience
- 6 Sigma Green belt preferred; experience using 5S and Lean principles is preferred
Requirements
- Bachelor's Degree in Engineering or related discipline such as Chemistry or Biomedical field
- 5+ years experience working in medical device or pharmaceutical industry preferred
- Prior experience working with radioisotopes preferred
- 3+ years of site management experience
- 10+ years of leadership experience
- 6 Sigma Green belt preferred
- Experience using 5S and Lean principles preferred
Benefits
- Paid Sick Time
- Vacation Time
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- 401(k) Matching
- Annual Bonus
Company overview
Sirtex Medical Limited is a global medical device company specializing in targeted radiation therapies for liver cancer. Founded in 1997 in Australia, the company has established itself as a leader in minimally invasive oncology treatments with its flagship product, SIR-Spheres Y-90 resin microspheres. This innovative medical device delivers selective internal radiation therapy (SIRT) for inoperable liver tumors, providing a treatment option for patients with primary liver cancer and metastatic colorectal cancer. The company operates globally with offices and production facilities in the United States, Australia, Germany, and Singapore, serving over 1,300 medical centers across more than 50 countries. Sirtex has supplied more than 100,000 doses of its SIR-Spheres microspheres, which work by delivering high-energy beta radiation directly to liver tumors through the hepatic artery, sparing healthy tissue while achieving radiation doses up to 40 times higher than conventional radiotherapy. The company was acquired by China Grand Pharmaceutical and Healthcare Holdings Ltd. and CDH Genetech in 2018 and is currently led by CEO Kevin R. Smith. Sirtex continues to advance cancer treatment through research collaborations and strategic partnerships focused on improving patient outcomes in oncology.